Antibody-drug conjugates emerge as potent anti-tumor agents for gynecological cancers
Gynecological cancers, primarily cervical, ovarian, and uterine cancer, continue to be a significant threat to women’s health worldwide. While surgery and chemotherapy are the current standard treatment, patients often face…